STI Expert Hour Webinar – Navigating the Bicillin L-A Shortage: A Conversation with PharmD Dr. Kathy Yang
January 31, 2024
12:00PM-1:15PM (PST)
1.25 CME units at no cost
Please note: No CME available for viewing the webinar recording.
Learning Objectives
List at least 2 factors contributing to ongoing Bicillin L-A shortages
Describe a framework for prioritizing Bicillin L-A when supplies are limited
Name potential alternative treatments for syphilis in non-pregnant people
Develop a decision-making process for the treatment of syphilis when standard guidelines cannot be followed or when data is insufficient.
Meet Our Expert: Kathy Yang, PharmD, MPH
Dr. Yang is a Health Sciences Clinical Professor in the Department of Clinical Pharmacy and the Co-Vice Dean of Clinical Innovation and Entrepreneurship at the University of California, San Francisco School of Pharmacy. She is also an Infectious Diseases Clinical Pharmacist in the UCSF Medical Center. Dr. Yang specializes in pharmacokinetic and pharmacodynamic optimization of the treatment of multi-drug resistant infections, particularly gram-negative bacteria such as Pseudomonas aeruginosa. For the past 3 years, Dr. Yang has focused her efforts on the clinical management of COVID-19.
2023 Hawai’i STI Clinical Update
October 17, 2023
9AM-5PM (HST)
Honolulu, HI / Virtual
1-day in-person and virtual training covering the following topics:
Syphilis in Pregnancy
Congenital Syphilis
Gonorrhea (GC)/Chlamydia (CT), including extragenital testing
Dermatologic manifestations of STIs – Urethritis/Vaginitis (including syndromic management)
Sexual assault and STIs
Presented by:
Kelly Johnson, MD,MPH, Medical Director, California Prevention Training Center
Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
Alan Katz, MD, MPH, Staff Physician, Hawai’i State Department of Health
Moderator: Breena Gaskov, BS, Outreach Epidemiological Specialist, Hawai’i State Department of Health
Learning Objectives
Explain prenatal syphilis screening and treatment recommendations
Describe the clinical and public health approaches to GC/CT prevention
Summarize data from recent studies exploring the use of doxy PEP to prevent bacterial STIs
Compare potential strategies for doxy-PEP implementation in clinical settings
Recognize dermatologic signs of sexually transmitted infections (STIs)
Delineate treatment approaches for syndromes suggestive of STIs
STI Clinical Update Humboldt County-Addressing the Rise of Syphilis: A Review of Clinical Management of Syphilis and Congenital Syphilis for Health Care Providers
Presented by Drs. Kathleen Jacobson and Wyatt Hanft
Describe the stages of syphilis and the recommended treatment and follow up for people with syphilis
Compare the traditional and reverse algorithm for syphilis screening
Please note: CME not offered for viewing the recording of the update
How to Prescribe Expedited Partner Therapy (EPT) for Sexually Transmitted Infections
Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with certain sexually transmitted infections (STIs) – including chlamydia (CT), gonorrhea (GC), and trichomoniasis – without the health care provider first examining the partner(s). EPT usually involves patient delivered partner therapy (PDPT), in which the patient delivers the medication or a prescription to their partner(s). While evaluating the partner and providing other needed health services would be ideal, this is often not feasible. EPT can be provided confidentially; it is effective, safe, acceptable to patients and partners, and helps to ensure timely partner treatment.
This resource contains information on how to prescribe EPT in California, including sample prescriptions, information on billing/reimbursement, and patient-facing materials.
Examination and Interpretation of Wet Preparations of Vaginal Specimens
In-person laboratory course onsite at the UC San Francisco campus
Intended for practicing clinicians with prior wet mount experience and microscopy skills
Capacity limited to 8 persons
The course begins with a fifteen minute didactic presentation on applicable issues of CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis. This will be followed by a fifteen minute video that details through the microscope footage of findings on VWM including trichomads, yeast and clue cells associated with BV. The remaining two and one-half hours consists of experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). During this portion of the training, participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.
Learning Objectives
Practice proper preparation of saline and KOH specimens of vaginal fluid to increase viability of specimens for microscopic evaluation.
Perform proper use of the light microscope to improve examination of saline and KOH wet mount specimens.
Assess wet mount microscopy specimens to appropriately interpret findings that support diagnosis of vulvovaginal candidiasis, bacterial vaginosis or trichomoniaisis.
STI Clinical Update Webinar: California Mpox Update for Healthcare Providers – October 2023
Thursday, October 26, 2023 12:00 PM – 1:30 PM (PDT)
The California Department of Public Health (CDPH) continues to see statewide Mpox activity, including a large cluster in Los Angeles County. This webinar, presented by the California Prevention Training Center (CAPTC), features CDPH’s Mpox Clinical and Epidemiology teams, who will provide a clinical update and epidemiological overview of Mpox, and discuss new research findings relevant to primary care and other healthcare providers, including data on transmission, vaccine equity, and vaccine effectiveness. A question-and-answer session will follow.
Presented by:
Kayla Saadeh, MPH Mpox Epidemiology Unit Lead California Department of Public Health
Jessica Watson, MD, MPH Mpox Public Health Medical Officer and Acting Clinical Lead California Department of Public Health
Learning Objectives
Identify the clinical and epidemiological factors leading to Mpox infection, transmission, and severity as well as treatment options.
Apply the latest information and research on Mpox, including transmission characteristics, vaccine equity, and vaccine effectiveness, to your clinical practice to ensure patients are appropriately vaccinated, diagnosed, tested, and treated for Mpox.
Please note: CME not available for viewing the webinar recording.
What, how, and why to talk to your clients about Doxy-PEP.
Presented by Drs. Kurtis Mohr and Rosalyn Plotzker
Registration for CME purposes closes three days before the webinar. After that time, you will be able to join the webinar, but you will not be able to get CME.
Chlamydia is an STI that can manage to damage our body in oh so many places. Watch this webinar to learn Everything about this “cloaked” assailant: from stats & numbers, to pathophys’, fevers, chills, and burning whiz! Plus screening, treatment & prevention, of course!
Learning Objectives
Recognize the different sequelae of sexually transmitted C. trachomatis and their recommended treatments
Know the recommended screening strategies C. trachomatis
Meet our Experts
Kurtis Mohr, MD, AAHIVM Dr. Mohr is a Family Medicine trained physician and recent 2022 graduate from Kaiser Permanente’s HIV Fellowship Program. He joined the California Department of Public Health in November 2022 as a Public Health Medical Officer in the STD Control Branch. His work focuses on preventative measures such as DoxyPEP and Hepatitis B & C screening outreach, along with Disseminated Gonococcal Infection (DGI) investigations.
Rosalyn Plotzker, MD, MPH Dr. Plotzker is an Assistant Professor in the UCSF Department of Epidemiology and Biostatistics. She completed a Fellowship in Sexually Transmitted Diseases with the CAPTC and CDPH. She serves as a Public Health Medical Officer in the STD Control Branch at CDPH.
May 2023 Is PrEP for Me: Addressing PrEP Disparities for Black People (Part 2)
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.
